期刊文献+

甘精胰岛素结合瑞格列奈治疗2型糖尿病50例临床效果观察

下载PDF
导出
摘要 目的观察甘精胰岛素结合瑞格列奈治疗2型糖尿病的临床效果。方法选取2013年10月—2014年10月来该院进行治疗的2型糖尿病患者100例,在其知情并同意的情况下分为对照组和观察组,每组50例。对照组患者采用预混胰岛素进行治疗,观察组患者采用甘精胰岛素结合瑞格列奈进行治疗,观察两组患者治疗的情况。结果两组患者经过治疗后糖化红蛋白,2 h PG、空腹血糖水平均有所下降,但是观察组患者的治疗效果更为明显,差异有统计学意义(P<0.05)。结论 2型糖尿病患者在治疗上采用甘精胰岛素结合瑞格列奈的方式具有维持血糖稳定、减少胰岛素使用量、低血糖情况发生率低的特点,能够提升治疗的总体效果和患者的生存质量,是临床治疗中较为理想的治疗方案,值得推广应用。
作者 李彩艳
出处 《糖尿病新世界》 2015年第1期22-22,共1页 Diabetes New World Magazine
  • 相关文献

参考文献3

二级参考文献40

  • 1Meneghini LF, Rosenberg KH, Koenen C, et al. Insulin detemir improves glycaemie control with less hypoglyeaemia and no weight gain in patientswith type 2 diabeteswho were insulin naive or treated with NPZI or insulin glargine: clinical practice experience from a German subgroup of the PRED ICTIVE study[J]. Diabetes Obes Metab,2007,9 (3) : 418-427.
  • 2Heise T, Eckers U, Kanc K, et al. The pharmacokinetic and pharmacodynamic properties of different formulations of biphasic insulin aspart : a randomized, glucose clamp, crossover study [J].Diabetes Technol Ther,21108,10 (6) : 4792485.
  • 3Rosenstock J, DaviesM, Home PD, et al. A randomised, 52 week, treat to target trial comparing insulin detemir with insulin glargine when administered as add on to glucose lowering drugs in insulin naive people with type diabetes[J]. Diabetologia,2008,51 (3) :408-416.
  • 4Floch J P, Lvy M,Mosnier P H,et a l. Comparison of once versus twice daily administration of insulin detemir, used with mealtime insulin aspart,in basalbolus therapy for type1 diabe tes: assessment of detemir administration in a progressive treat to target trial (ADAPT)E J2. Diabetes Care,2009,32 (1) : 32-37.
  • 5Fajardo MC, Rivas FM. Less weight gain and hypoglycaemia with once daily insulin detemir than NPH insulin in intensification of insulin therapy in overweight Type 2 diabetes patiems: the PRED ICTIVE BMI clinical trial[J]. Diabet Med, 201)8,25 ( 8 ):916-923.
  • 6Danne T,Datz N, Endahl I.,et al. Insulin detemir is character ized by a more reproducible pharmacokinetic profile than insu lin glargine in children and adolescents with type 1 diabetes: results from a randomized, doubleblind, controlled trial[J]. Pe diatr Diabetes,2008,9 (6) : 554-560.
  • 7宁光.发挥胰岛素效能治疗达标[N].中国医学论坛报,2003,10-23(16).
  • 8Kupecz D, Berardinelli C. Drug and device approval highlights from 2001 [J]. Nurse Pract ,2002,27(2) :15 - 16,21 -23.
  • 9Levien TL, Baker DE,White JR Jr, et al. Insulin glargine:a new basal insulin [ J ]. Ann Pharmacother, 2002, 36 ( 6 ): 1019 -1027.
  • 10李萍.新胰岛素制剂研究和临床应用[EB/OL].http://www.511511. com. cn/news/documents/20030605171357862. htm -22k,2003-05-15/2003-12-20.

共引文献110

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部